Raia Drogasil S.A.

São Paulo Stock Exchange RADL3.SA

Raia Drogasil S.A. EBITDA Margin for the year ending December 31, 2023: 8.10%

Raia Drogasil S.A. EBITDA Margin is 8.10% for the year ending December 31, 2023, a -26.49% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Raia Drogasil S.A. EBITDA Margin for the year ending December 31, 2022 was 11.02%, a 2.34% change year over year.
Raia Drogasil S.A. EBITDA Margin for the year ending December 31, 2021 was 10.77%, a 6.37% change year over year.
Raia Drogasil S.A. EBITDA Margin for the year ending December 31, 2020 was 10.12%, a -18.30% change year over year.
Raia Drogasil S.A. EBITDA Margin for the year ending December 31, 2019 was 12.39%, a 64.93% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

São Paulo Stock Exchange: RADL3.SA

Raia Drogasil S.A.

CEO	Mr. Marcílio D'Amigo Pousada
IPO Date	Jan. 6, 2000
Location	Brazil
Headquarters	Av. Corifeu de Azevedo Marques, 3097
Employees	62,402
Sector	Health Care
Industries Drugstores & Retail Pharmacies Cosmetics Pharmaceuticals Specialty Retail

Description

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Key trends

Past 5 years